SCHEMBL19980451

SCHEMBL19980451

CCC/C(=N\N=C(/C)Cc1cccc(F)c1)C(=O)N[C@H](C)CCc1ccc(F)cc1NC=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
ATM Q13315 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HPGD P15428 1/20 0.32
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
HTT P42858 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TP53 P04637 1/20 0.30
SAE1 Q9UBE0 1/20 0.30
UBA2 Q9UBT2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20344607 0.69 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL20344640 0.63 ALOX15 (0.42) SMN1; SMN2TSHRMEN1KMT2AHTT
SCHEMBL22048476 0.63 MEN1 (0.40) ALDH1A1SMN1; SMN2ATMMAPK1MEN1
SCHEMBL5323948 0.62 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL19979980 0.62 KDM4E (0.46) ALDH1A1SMN1; SMN2MEN1KMT2ACYP2C19
SCHEMBL23188943 0.61 CNR2 (0.38) TSHRMEN1KMT2ACYP2C9CYP2C19
SCHEMBL22048475 0.61 SMN1; SMN2 (0.45) ALDH1A1SMN1; SMN2MAPK1MEN1KMT2A
SCHEMBL11080103 0.59 VNN1 (0.52)
SCHEMBL23188871 0.59 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2MAPK1MEN1KMT2A
SCHEMBL10137784 0.58 SLC1A1 (0.46) TSHRMEN1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2956452-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2018-03-21 EP disclosed